Geron Corporation is an American biotechnology company focused on researching and developing therapeutic drugs for the treatment of various oncological diseases and other serious conditions. The company specializes in telomerase inhibition therapy, a process that targets the suppression of uncontrolled cell growth in cancerous conditions. Geron Corporation focuses on clinical trials and drug development with the potential to alleviate patient suffering and improve their quality of life. The company also has research and licensing programs for the development of new therapeutic drugs. Investing in Geron Corporation (GERN) shares may be an interesting choice for investors who follow the biotechnology industry and seek investment opportunities in a company with an innovative approach to treating serious diseases.